Ravichandran Vishwa
YOU?
Author Swipe
View article: Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment
Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment Open
Brain cancer remains among the most lethal malignancies worldwide, with approximately 321,476 new cases and 248,305 deaths reported globally in 2022. The treatment of malignant brain tumors presents substantial clinical challenges, primari…
View article: Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy
Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy Open
Capsaicin (CAPS), a bioactive alkaloid derived from chili peppers, has garnered significant interest for its potential role as a combinatorial and chemosensitizing agent in cancer therapy. Numerous preclinical studies have demonstrated tha…
View article: Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials Open
View article: Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases
Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases Open
View article: Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far? Open
View article: Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents
Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents Open
Head and neck cancers (HNC) encompass a broad spectrum of neoplastic disorders characterized by significant morbidity and mortality. While contemporary therapeutic interventions offer promise, challenges persist due to tumor recurrence and…
View article: Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? Open
Curcumin has been credited with a wide spectrum of pharmacological properties for the prevention and treatment of several chronic diseases such as arthritis, autoimmune diseases, cancer, cardiovascular diseases, diabetes, hemoglobinopathie…